Another monoclonal antibody for Alzheimer’s to get FDA review By / On July 13, 2022 / At 6:40 pm / In Chemical world 9 Views Some scientists aren’t hopeful that lecanemab, following in the footsteps of its unsuccessful predecessor, will shake things up Post navigation Prev PostChemistry in Pictures: Separation fascination Next PostSwitch to safer basic chemicals, activists tell industry You May Also Like Chemistry in Pictures: Electronic pigment On August 9, 2022 | In Chemical world Protective treatment for Covid-19 makes minimal impact On August 9, 2022 | In Chemical world Manganese coordination polymer separates xylene isomers On August 9, 2022 | In Chemical world